one) and Drug Interactions (7)]. The risk of hypoglycemia could be reduced by a reduction while in the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify patients utilizing these concomitant drugs of the potential risk of hypoglycemia and educate them